vers la météo de la validation par utilisateur
+----------------------------COMP:V-N(In)---------------------------+ | +-------------MOD_ATT:N-N------------+ | +------------COMP:N-N(of)------------+ | | +----------MOD_ATT:N-ADJ---------+ | | +------MOD_ATT:N-ADJ-----+ | | | +-------MOD_ATT:N-ADJ-------+ | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+COMP:N-N(from+ | | | +----MOD_ATT:N-ADJ---+--SUBJ:V-N-+--OBJ:V-N-+ | | +MOD_ATT+ | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) COMP:N-N(from) (osteoblast,@card@) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) COMP:V-N(In) (decrease,osteoblast) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ | +-------------MOD_ATT:N-N------------+ | | | +----------MOD_ATT:N-ADJ---------+ | +------------COMP:N-N(of)------------+ | | | +-------MOD_ATT:N-ADJ-------+ | | +------MOD_ATT:N-ADJ-----+ | | | | +----MOD_ATT:N-ADJ---+ | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+COMP:N-N(from+ | | | | +-MOD_ATT:N-N+--SUBJ:V-N-+--OBJ:V-N-+ | | +MOD_ATT+ | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) COMP:N-N(from) (osteoblast,@card@) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) MOD_ATT:N-N (cycloheximide,calvaria) COMP:V-N(In) (decrease,osteoblast) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ +------------COMP:N-N(of)------------+ | +-------------MOD_ATT:N-N------------+ | | +------MOD_ATT:N-ADJ-----+ | | +----------MOD_ATT:N-ADJ---------+ | | | +----MOD_ATT:N-N----+ | | | +-------MOD_ATT:N-ADJ-------+ | | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+COMP:N-N(from+ | | | +----MOD_ATT:N-ADJ---+--SUBJ:V-N-+--OBJ:V-N-+ | | | +MOD_ATT+ | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) COMP:N-N(from) (osteoblast,@card@) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) COMP:V-N(In) (decrease,osteoblast) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,IGF) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ | +-------------MOD_ATT:N-N------------+ | +------------COMP:N-N(of)------------+ | | +----------MOD_ATT:N-ADJ---------+ | | +------MOD_ATT:N-ADJ-----+ | | | +-------MOD_ATT:N-ADJ-------+ | | | +----MOD_ATT:N-N----+ | | | | +----MOD_ATT:N-ADJ---+ | | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+COMP:N-N(from+ | | | | +-MOD_ATT:N-N+--SUBJ:V-N-+--OBJ:V-N-+ | | | +MOD_ATT+ | | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) COMP:N-N(from) (osteoblast,@card@) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) MOD_ATT:N-N (cycloheximide,calvaria) COMP:V-N(In) (decrease,osteoblast) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,IGF) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ +--------------COMP:N-N(from)--------------+ | | +------MOD_ATT:N-N------+ | +------------COMP:N-N(of)------------+ | | +---MOD_ATT:N-ADJ---+ | | +------MOD_ATT:N-ADJ-----+ | | | +-MOD_ATT:N-ADJ+ | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | +MOD_ATT+ +--SUBJ:V-N-+--OBJ:V-N-+ | | +MOD_ATT+ | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) COMP:N-N(from) (osteoblast,calvaria) MOD_ATT:N-N (calvaria,day) MOD_ATT:N-ADJ (calvaria,old) MOD_ATT:N-ADJ (calvaria,fetal) MOD_ATT:N-ADJ (calvaria,__SP__) COMP:V-N(In) (decrease,osteoblast) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ +--------------COMP:N-N(from)--------------+ | +------------COMP:N-N(of)------------+ | +------MOD_ATT:N-N------+ | | +------MOD_ATT:N-ADJ-----+ | | +---MOD_ATT:N-ADJ---+ | | | +----MOD_ATT:N-N----+ | | | +-MOD_ATT:N-ADJ+ | | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | +MOD_ATT+ +--SUBJ:V-N-+--OBJ:V-N-+ | | | +MOD_ATT+ | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) COMP:N-N(from) (osteoblast,calvaria) MOD_ATT:N-N (calvaria,day) MOD_ATT:N-ADJ (calvaria,old) MOD_ATT:N-ADJ (calvaria,fetal) MOD_ATT:N-ADJ (calvaria,__SP__) COMP:V-N(In) (decrease,osteoblast) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,IGF) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ | +--------------------COMP:V-N(from)-------------------+ | | +-------------MOD_ATT:N-N------------+ | +------------COMP:N-N(of)------------+ | | | +----------MOD_ATT:N-ADJ---------+ | | +------MOD_ATT:N-ADJ-----+ | | | | +-------MOD_ATT:N-ADJ-------+ | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | | +----MOD_ATT:N-ADJ---+--SUBJ:V-N-+--OBJ:V-N-+ | | +MOD_ATT+ | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) COMP:V-N(In) (decrease,osteoblast) COMP:V-N(from) (decrease,@card@) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ | +--------------------COMP:V-N(from)-------------------+ | | +-------------MOD_ATT:N-N------------+ | | | | +----------MOD_ATT:N-ADJ---------+ | +------------COMP:N-N(of)------------+ | | | | +-------MOD_ATT:N-ADJ-------+ | | +------MOD_ATT:N-ADJ-----+ | | | | | +----MOD_ATT:N-ADJ---+ | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | | | +-MOD_ATT:N-N+--SUBJ:V-N-+--OBJ:V-N-+ | | +MOD_ATT+ | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) MOD_ATT:N-N (cycloheximide,calvaria) COMP:V-N(In) (decrease,osteoblast) COMP:V-N(from) (decrease,@card@) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ | +------MOD_ATT:N-N------+ | +------------COMP:N-N(of)------------+ | | +---MOD_ATT:N-ADJ---+ | | +------MOD_ATT:N-ADJ-----+ | | | +-MOD_ATT:N-ADJ+-----COMP:V-N(from)-----+ | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | +MOD_ATT+ +--SUBJ:V-N-+--OBJ:V-N-+ | | +MOD_ATT+ | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) MOD_ATT:N-N (calvaria,day) MOD_ATT:N-ADJ (calvaria,old) MOD_ATT:N-ADJ (calvaria,fetal) MOD_ATT:N-ADJ (calvaria,__SP__) COMP:V-N(In) (decrease,osteoblast) COMP:V-N(from) (decrease,calvaria) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ | +--------------------COMP:V-N(from)-------------------+ +------------COMP:N-N(of)------------+ | | +-------------MOD_ATT:N-N------------+ | | +------MOD_ATT:N-ADJ-----+ | | | +----------MOD_ATT:N-ADJ---------+ | | | +----MOD_ATT:N-N----+ | | | | +-------MOD_ATT:N-ADJ-------+ | | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | | +----MOD_ATT:N-ADJ---+--SUBJ:V-N-+--OBJ:V-N-+ | | | +MOD_ATT+ | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) COMP:V-N(In) (decrease,osteoblast) COMP:V-N(from) (decrease,@card@) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,IGF) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ | +--------------------COMP:V-N(from)-------------------+ | | +-------------MOD_ATT:N-N------------+ | +------------COMP:N-N(of)------------+ | | | +----------MOD_ATT:N-ADJ---------+ | | +------MOD_ATT:N-ADJ-----+ | | | | +-------MOD_ATT:N-ADJ-------+ | | | +----MOD_ATT:N-N----+ | | | | | +----MOD_ATT:N-ADJ---+ | | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | | | +-MOD_ATT:N-N+--SUBJ:V-N-+--OBJ:V-N-+ | | | +MOD_ATT+ | | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) MOD_ATT:N-N (cycloheximide,day) MOD_ATT:N-ADJ (cycloheximide,old) MOD_ATT:N-ADJ (cycloheximide,fetal) MOD_ATT:N-ADJ (cycloheximide,__SP__) MOD_ATT:N-N (cycloheximide,calvaria) COMP:V-N(In) (decrease,osteoblast) COMP:V-N(from) (decrease,@card@) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,IGF) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])
+----------------------------COMP:V-N(In)---------------------------+ +------------COMP:N-N(of)------------+ | +------MOD_ATT:N-N------+ | | +------MOD_ATT:N-ADJ-----+ | | +---MOD_ATT:N-ADJ---+ | | | +----MOD_ATT:N-N----+ | | | +-MOD_ATT:N-ADJ+-----COMP:V-N(from)-----+ | | | +--MOD_ATT:N-N--+ +MOD_ATT:N+ | | | +MOD_ATT+ +--SUBJ:V-N-+--OBJ:V-N-+ | | | +MOD_ATT+ | | | | | | | | | | | | | | | In cultured osteoblasts from 220.0 day old fetal __SP__ calvaria , cycloheximide decreases expression of __SP__ IGF BP5 [__NODE__] mRNA . MOD_ATT:N-ADJ (osteoblast,cultured) MOD_ATT:N-N (calvaria,day) MOD_ATT:N-ADJ (calvaria,old) MOD_ATT:N-ADJ (calvaria,fetal) MOD_ATT:N-ADJ (calvaria,__SP__) COMP:V-N(In) (decrease,osteoblast) COMP:V-N(from) (decrease,calvaria) SUBJ:V-N (decrease,cycloheximide) OBJ:V-N (decrease,expression) COMP:N-N(of) (expression,mRNA) MOD_ATT:N-ADJ (mRNA,__SP__) MOD_ATT:N-N (mRNA,IGF) MOD_ATT:N-N (mRNA,BP5) MOD_ATT:N-N (mRNA,[__NODE__])